Yorvipath 73362-0102-01

Generic: Palopegteriparatide

Package NDC

73362-0102-01

Manufacturer: Ascendis Pharma, Endocrinology, Inc.
Dosage Form: Injection, Solution
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: August 9, 2024
Listing Expires: December 31, 2027
Application: NDA216490

Need to source Yorvipath? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Palopegteriparatide	420 ug/1.4mL

Drug Class

Parathyroid Hormone Analog [EPC]Parathyroid Hormone [CS]

Selected Package

73362-0102-01Selected

2 BOX in 1 CARTON (73362-102-01) / 1 SYRINGE in 1 BOX (73362-102-02) / 1 CARTRIDGE in 1 SYRINGE (73362-102-03) / 1.4 mL in 1 CARTRIDGE